Compositions and methods for treating late stage lung cancer

TW202635345APending Publication Date: 2026-09-01ASTRAZENECA AB
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114144792
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2019-09-05
Filing Date
2020-09-04
Publication Date
2026-09-01

Smart Images

  • Figure 00000000_0000_ABST
    Figure 00000000_0000_ABST
Patent Text Reader

Abstract

Disclosed are methods for treating extensive-stage small-cell lung cancer (ES-SCLC) with an antibody that inhibits PD1 / PD-L1 activity in combination with etoposide and a platinum-based therapeutic agent.
Need to check novelty before this filing date? Find Prior Art